Endoscopic Submucosal Dissection for Recurrent or Residual Superficial Esophageal Cancer after Chemoradiotherapy: Two Cases.
- Author:
Changhyeok HWANG
1
;
Young Hoon YOUN
;
Sung Eun CHOI
;
Young Hak JUNG
;
Hae Yeul PARK
;
Jae Jun PARK
;
Jie Hyun KIM
;
Hyojin PARK
Author Information
- Publication Type:Case Report
- Keywords: Esophageal neoplasms; Chemoradiotherapy; Endoscopic submucosal dissection
- MeSH: Carcinoma, Squamous Cell; Chemoradiotherapy*; Endoscopy, Digestive System; Esophageal Neoplasms*; Follow-Up Studies; Humans; Middle Aged; Recurrence
- From:Clinical Endoscopy 2015;48(6):553-557
- CountryRepublic of Korea
- Language:English
- Abstract: We report two cases of endoscopic submucosal dissection (ESD) for recurrent or residual esophageal squamous cell carcinoma (ESCC) lesions after chemoradiotherapy for advanced esophageal cancer. Case 1 involved a 64-year-old man who had previously undergone chemoradiotherapy for advanced ESCC and achieved a complete response (CR) for 22 months, until metachronous recurrent superficial ESCC was detected on follow-up esophagogastroduodenoscopy (EGD). We performed ESD and found no evidence of recurrence for 24 months. Case 2 involved a 59-year-old man who had previously undergone chemoradiotherapy for advanced ESCC. He responded favorably to treatment, and most of the tumor had disappeared on follow-up EGD 4 months later. However, there were two residual superficial esophageal lugol-voiding lesions. We performed ESD, and he had a CR for 32 months thereafter. ESD can be considered a viable treatment option for recurrent or residual superficial ESCC after chemoradiotherapy for advanced esophageal cancer.
